Royston, United Kingdom

Paul Mortenson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Elixir Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Mortenson. Retrieved from https://idiyas.com/inventor/paul-mortenson-1u3pu38b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Mortenson

Introduction

Paul Mortenson is a notable inventor based in Royston, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his work on sulfonamide compounds. His innovative approach has led to the development of compounds that modulate GHS-R, which have potential therapeutic applications.

Latest Patents

Mortenson holds a patent for "Sulfonamide compounds and uses thereof." This patent describes compounds that can modulate GHS-R, showcasing his expertise in medicinal chemistry. He has been granted 1 patent for his work in this area.

Career Highlights

Mortenson is currently employed at Elixir Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Mortenson has collaborated with esteemed colleagues such as Jeffrey O. Saunders and Thomas Stephen Coulter. These partnerships have enhanced his research and contributed to the success of his projects.

Conclusion

Paul Mortenson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…